NVNOWライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (29 5月 2024 @ 05:00):

Stats
本日の出来高	24 254
平均出来高	8 352
時価総額	63.58M
EPS	$-0.310 ( Q1 \| 2024-05-08 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 43.86
ATR14	$0.0120 (190.48%)

ABMD 0.00%

AMIX -4.95%

BBLGW -21.85%

BVS 0.52%

COCH 3.06%

DHAI -3.26%

DHAIW -22.93%

DNAY 8.33%

EYES -5.05%

GBS -1.58%

HSCS -1.70%

HSCSW -32.26%

IINNW 1.61%

INVO -3.33%

LFWD 1.26%

MDAI -2.22%

MGRM 3.86%

MXCT -2.00%

NVNOW -32.98%

NXL -42.91%

NXLIW -15.00%

OSA -7.35%

OSAAW -6.40%

PAVMW 105.67%

PAVMZ 0.00%

PETVW 0.00%

QTI 2.21%

QTNT 0.00%

Insider Trading

Date	Person	Action	Amount	type
2023-12-05	Glynn Craig	Buy	75 000	Stock Options
2023-12-05	Jenusaitis Matthew	Buy	13 856	Stock Options
2023-12-05	Alavi Hamed	Buy	100 000	Stock Options
2023-12-05	Glickman Marc H.	Buy	100 000	Stock Options
2023-12-05	Gray Robert	Buy	13 856	Stock Options

INSIDER POWER
51.32
Last 96 transactions
Buy: 7 138 437 \| Sell: 4 126 509

ボリューム相関

長: -0.36 (neutral)

短: 0.00 (neutral)

Signal:(34.031) Neutral

enVVeno Medical 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

enVVeno Medical 相関 - 通貨/商品

0.58
( weak )

-0.57
( weak negative )

0.00
( neutral )

0.43
( neutral )

0.00
( neutral )

-0.38
( neutral )

enVVeno Medical 財務諸表

Annual	2023
収益:	$0
総利益:	$-546 000 (0.00 %)
EPS:	$-1.910

FY	2023
収益:	$0
総利益:	$-546 000 (0.00 %)
EPS:	$-1.910

FY	2022
収益:	$0
総利益:	$-525 000 (0.00 %)
EPS:	$-2.16

FY	2021
収益:	$0.00
総利益:	$0.00 (0.00 %)
EPS:	$-1.904

Financial Reports:

No articles found.

enVVeno Medical Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

enVVeno Medical

enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company\'s lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.